Saheki T, Kobayashi K, Ichiki H, Matuo S, Tatsuno M, Imamura Y, Inoue I, Noda T, Hagihara S
Department of Biochemistry, Faculty of Medicine, Kagoshima University.
Enzyme. 1987;38(1-4):227-32. doi: 10.1159/000469209.
This paper deals with enzymological, immunochemical and molecular genetic analyses of citrullinemia and argininosuccinic aciduria. Citrullinemia has been classified by Saheki et al. [J. inher. Metab. Dis. 8: 155-156, 1985] into three types from the properties of the deficient argininosuccinate synthetase (ASS) of the patients. Analysis of hepatic mRNA coding for ASS revealed certain characteristics in type II and III citrullinemic patients whose hepatic ASS protein was low. A newly developed enzyme-linked immunosorbent assay (ELISA) of argininosuccinate lyase (ASL) protein showed that 8 out of ten cases of argininosuccinic aciduria had no detectable ASL protein in the liver, erythrocytes, cultured skin fibroblasts or cultured amniocytes.
本文论述了瓜氨酸血症和精氨琥珀酸尿症的酶学、免疫化学及分子遗传学分析。Saheki等人[《遗传代谢病杂志》8: 155 - 156, 1985]根据患者精氨琥珀酸合成酶(ASS)缺陷的性质,将瓜氨酸血症分为三种类型。对编码ASS的肝脏mRNA的分析揭示了II型和III型瓜氨酸血症患者的某些特征,这些患者的肝脏ASS蛋白水平较低。一种新开发的精氨琥珀酸裂解酶(ASL)蛋白的酶联免疫吸附测定(ELISA)表明,十例精氨琥珀酸尿症患者中有八例在肝脏、红细胞、培养的皮肤成纤维细胞或培养的羊水中未检测到ASL蛋白。